Mather Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Mather Group's BIIB Position: Q2 2026 in Review
Mather Group increased its Biogen (BIIB) stake by 3.5% in Q2 2026, buying an estimated $10.3K and bringing the position to 1,588 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #635.
Mather Group first reported a position in BIIB in Q2 2020 and has held it in 17 quarters since. The position peaked at $466K in Q2 2023. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Mather Group held 1,588 shares of Biogen worth $343K as of Q2 2026.
- Mather Group bought 54 Biogen shares in Q2 2026, an estimated $10.3K.
- Biogen made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #635 holding.
- Mather Group first reported a position in Biogen in Q2 2020 and has held it in 17 quarters since.
- Mather Group's Biogen position peaked at $466K in Q2 2023.
- 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.